ANGARANO, GIOACCHINO
 Distribuzione geografica
Continente #
NA - Nord America 5.805
EU - Europa 4.386
AS - Asia 3.418
SA - Sud America 331
Continente sconosciuto - Info sul continente non disponibili 82
AF - Africa 49
OC - Oceania 9
Totale 14.080
Nazione #
US - Stati Uniti d'America 5.741
CN - Cina 1.404
IE - Irlanda 1.250
UA - Ucraina 1.012
SG - Singapore 944
RU - Federazione Russa 602
SE - Svezia 545
HK - Hong Kong 341
TR - Turchia 313
BR - Brasile 273
FI - Finlandia 225
IN - India 206
IT - Italia 175
DE - Germania 168
FR - Francia 152
GB - Regno Unito 149
VN - Vietnam 79
BD - Bangladesh 36
BE - Belgio 30
CA - Canada 29
IQ - Iraq 22
CZ - Repubblica Ceca 21
MX - Messico 19
ZA - Sudafrica 16
AR - Argentina 14
ES - Italia 14
EU - Europa 12
EC - Ecuador 10
AT - Austria 9
NL - Olanda 9
PK - Pakistan 9
VE - Venezuela 9
CL - Cile 8
ID - Indonesia 8
AU - Australia 7
CO - Colombia 7
JP - Giappone 7
OM - Oman 7
PE - Perù 7
KE - Kenya 6
RO - Romania 6
TN - Tunisia 6
AZ - Azerbaigian 5
CR - Costa Rica 5
LT - Lituania 5
MY - Malesia 5
PL - Polonia 5
SA - Arabia Saudita 5
AE - Emirati Arabi Uniti 4
DZ - Algeria 4
JO - Giordania 4
PH - Filippine 4
EG - Egitto 3
IL - Israele 3
JM - Giamaica 3
MA - Marocco 3
SN - Senegal 3
UZ - Uzbekistan 3
AL - Albania 2
HN - Honduras 2
NZ - Nuova Zelanda 2
PY - Paraguay 2
BG - Bulgaria 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CG - Congo 1
CH - Svizzera 1
CM - Camerun 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GN - Guinea 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
HT - Haiti 1
KZ - Kazakistan 1
LY - Libia 1
MK - Macedonia 1
MN - Mongolia 1
NP - Nepal 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TM - Turkmenistan 1
TT - Trinidad e Tobago 1
UG - Uganda 1
UY - Uruguay 1
ZW - Zimbabwe 1
Totale 14.010
Città #
Dublin 1.247
Chandler 754
San Jose 745
Jacksonville 717
Dearborn 625
Nanjing 408
Singapore 369
Hong Kong 339
Ashburn 331
Nyköping 255
Beijing 182
Nanchang 163
Santa Clara 156
Wilmington 154
San Mateo 146
Princeton 145
Ann Arbor 132
Lauterbourg 132
Moscow 115
Boardman 110
Dallas 87
Helsinki 79
Kunming 67
Hebei 60
Jiaxing 57
Shenyang 55
Tianjin 55
Woodbridge 50
The Dalles 47
Changsha 38
Los Angeles 38
Ho Chi Minh City 33
Des Moines 32
Hangzhou 32
Hilden 31
Brussels 30
Lanzhou 27
New York 26
Milan 23
Changchun 20
Orem 20
Guangzhou 19
Stevenage 19
Zhengzhou 19
Jinan 17
Ningbo 17
São Paulo 16
Brno 15
Taizhou 15
Hanoi 13
Shanghai 12
Auburn Hills 11
Dhaka 11
Rio de Janeiro 11
Chennai 10
Norwalk 10
Toronto 10
Brooklyn 9
Chicago 9
Baghdad 8
Da Nang 8
Nuremberg 8
Rome 8
Hefei 7
Saint Petersburg 7
San Francisco 7
Atlanta 6
Fuzhou 6
London 6
Mexico City 6
Munich 6
Naples 6
Baku 5
Belo Horizonte 5
Bologna 5
Boston 5
Campinas 5
Frankfurt am Main 5
Johannesburg 5
Manchester 5
Molfetta 5
Nairobi 5
Newark 5
Olomouc 5
Orange 5
Salvador 5
Sorocaba 5
Amman 4
Amsterdam 4
Augusta 4
Bari 4
Cape Town 4
Curitiba 4
Goiânia 4
Guayaquil 4
Lahore 4
Mumbai 4
New Delhi 4
Phoenix 4
San José 4
Totale 8.591
Nome #
A randomized controlled trial of a protease inhibitor (saquinavir) in combination with zidovudine in previously untreated patients with advanced HIV infection 134
Cerebral SPECT with 99mTc-HM-PAO and Magnetic Resonance in Drug Abusers and AIDS patients with Dementia 134
Associazione tra tubercolosi ed infezione da HIV: programma per uno studio multicentrico 132
PREVALEAT STUDY (PREMATURE VASCULAR LESIONS AND ANTIRETROVIRAL THERAPY). A COMPARATIVE STUDY BETWEEN PATIENTS TREATED WITH PI-INCLUDING REGIMENS VS NNRTI-INCLUDING REGIMENS. 132
Circulating immune complexes in HBsAg carriers with chronic hepatitis and other extra-hepatic manifestations 129
Distribuzione dell'anti-HAV in un campione di popolazione pugliese 127
Zidovudine prophylaxis after accidental exposure to HIV: the Italian experience 124
Fattori di contagiosita' nell'epidemiologia dell'epatite virale di tipo B 122
A randomized double-blind study of virological, clinical and safety effects of a combination of stavudine and didanosine versus zidovudine and didanosine in treatment-naive HIV-infected individuals 121
Mutations in the reverse transcriptase gene of HIV-1 from subjects after d4T/ddI dual therapy 121
Alterazioni oftalmoscopiche e fluorangiografiche in pazienti affetti da AIDS 120
Epidemiologia della epatite A in Puglia 120
Diagnosi sierologica dell'epatite acuta da virus A. Messa a punto e valutazione di tre metodiche per la determinazione delle IgM specifiche anti-HAV 118
Cell-mediated immunity and immunosuppressive therapy in HbsAg-positive chronic active hepatitis 117
Adherence as a gender issue: psychosocial factors influencing antiretroviral adherence in HIV-seropositive women 116
Long-term administration of Inosine-Pranobex (INPX) in anti-HIV asymptomatic carriers. Preliminary results of a controlled study 115
Ulteriore espansione dell'epidemia di HCV in pazienti emodializzati: valutazione clinico-epidemiologica alla luce dei tests diagnostici di II generazione 114
Clinica delle Micobatteriosi nei pazienti immunodepressi 114
AIDS 114
Il sistema HBeAg/anti-HBe nella infezione cronica da virus B dell'epatite 113
Comportamento dei linfociti T teofillino-sensibili nell'epatite da virus A, B, non-A,non-B. I.Aspetti metodologici 113
L'anticorpo antinucleare (anti-HBc) e patologia acuta e cronica del fegato da virus B dell'epatite 110
Archivio computerizzato per la gestione ambulatoriale ed in day hospital dei pazienti anti-HIV positivi 109
Studio epidemiologico della epatite cronica in relazione alla infezione da virus B dell'epatite 109
Ulcero-necrotic Herpes Simplex in a male patient affected by AIDS 109
Indagine sieroepidemiologica sulla infezione da HIV in soggetti osservati presso la Clinica Dermatologica di Bari 109
Chronic cryptococcal meningitis in an intravenous drug addict without evidence of infection by HIV-1,2 in southern Italy 108
Hepatitis B virus markers, alpha-fetoprotein and survival in fulminant viral hepatitis 108
Possible significance of antibodies to Legionella pneumophila in HIV-1 infected patients with acute respiratory illness 108
Valore prognostico dell'alfa-fetoproteina nella epatite acuta fulminante 108
Chlamydia pneumoniae respiratory infections among patients infected with the human immunodeficiency virus 107
Cerebral lesions in two AIDS patients: the possible role of Mycobacterium kansasii 107
Drug injection in jugular veins: a new risk factor for vascular diseases in HIV-infected patients? 107
Effect of antiretroviral therapy on cryptosporidiosis and microsporidiosis in patients infected with human immunodeficiency virus type 1 107
La candidosi orale recidivante e persistente nei pazienti con infezione da HIV-1. Schemi di trattamento 107
Chlamydia pneumoniae: a new opportunistic infectious agent in AIDS? 107
L'anti-HBc nella diagnostica della infezione da virus B dell'epatite 107
Valutazione di un test immunoenzimatico (ELISA) per la determinazione di un sistema Ag/Ab correlato all’epatite non-A,non-B post-trasfusionale 107
Drug-resistant tuberculosis in human immunodeficiency virus infected persons in Italy. The Italian Drug-Resistant Tuberculosis Study Group 106
Tuberculosis and Human Immunodeficiency Virus infection in Italy 106
I marcatori di infettività e diffusione della infezione da virus B dell'epatite in una unità dialitica 106
HBsAg loss is enough to discontinue long-term nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis B patients in real practice 106
Association between HIV p24 antigen in cerebrospinal fluid and severe complications in the central nervous system 105
Interazioni virus-ospite nell'infezione cronica da HBV 105
Burden of Disease in PWH Harboring a Multidrug-Resistant Virus: Data from the PRESTIGIO Registry 105
Ocular manifestations in HIV-seropositive patients 104
Survival of Zidovudine-treated patients with AIDS compared with that of contemporary untreated patients 104
Impact of mutations conferring reduced susceptibility to lamivudine on the response to antiretroviral therapy 104
Serological merkers predicting tuberculosis in human immunodeficiency virus-infected patients 103
Complicanze neurologiche di tipo encefalitico in corso di Rosolia 103
Risk of developing AIDS in newly seropositive intravenous drug abusers 102
A cyanobacterium-like body found in the stools of an HIV+ patient with diarrhoea 101
Prevalence of HBV genotypes in South American immigrants affected by HBV-related chronic active hepatitis. 101
La determinazione radioimmunologica delle IgM virus-specifiche nella diagnosi rapida di epatite virale di tipo A 101
Dosaggio radioimmunologico dell’HAV e delle IgA anti-HAV nelle feci di pazienti con epatite acuta di tipo A 100
Prevalence of cryptosporidiosis in HIV-infected patients with diarrhoeal illness 100
I sistemi HBsAg/anti-HBs ed eAg/anti-e nella epatite cronica 99
The Calculated Genetic Barrier for Antiretroviral Drug Resistance Substitutions Is Largely Similar for Different HIV-1 Subtypes 99
Real Versus Virtual Phenotype to Guide Treatment in Heavily Pretreated Patients: 48-Week Follow-Up of the Genotipo-Fenotipo di Resistenza (GenPheRex) Trial 98
Markers di repicazione virale (HBeAg) e attivita' DNA polimerasica nell'uremico cronico in trattamento emodialitico periodico 98
Trichosporon beigelii infection in AIDS patients undergoing antifungal prophylaxis: report of two cases 98
Longitudinal analysis of the 90K glycoprotein in the Italian HIV-seroconversion study: temporal trend and predictability of the maturity of HIV infection 98
Su due casi di coinfezione Leishmania-HIV osservati in Puglia 97
Man-to-woman sexual transmission of HIV: longitudinal study of 343 steady partners of infected men 97
Drug susceptibility patterns in 195 european patients de novo infected with drug resistant virus: implications for post-exposure prophylaxis 97
Choreoathetosis in acquired immune deficiency syndrome patients with cerebral toxoplasmosis 96
Anti-NEF antibodies and other predictors of disease progression in HIV-1 seropositive injecting drug users 96
Riattivazione spontanea della replica virale in portatori di HBV con patologia cronica del fegato 96
Transmission of zidovudine-resistant HIV-1 through heterosexual contacts 96
Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naive patients. I.CO.N.A. Study Group. Italian Cohort of Antiretroviral-Naive Patients 95
Rapporti tra immunocomplessi circolanti e virus B nelle epatiti croniche 95
Infectivity markers in HbsAg chronic carriers and intrafamilial spread of hepatitis B virus infection 94
Parkinsonism in a patient with AIDS and cerebral opportunistic granulomatous lesions 94
Topical thymopentin therapy in HIV positive patients with recurrent oral candidiasis: a pilot study 94
Storia naturale dell'infezione da HIV nelle donne 94
I centri dialisi: un modello epidemiologico di diffusione del virus epatico C 94
Studio di una epidemia di epatite virale 94
Gli immunocomplessi nelle epatiti croniche 93
La tubercolosi farmacoresistente 93
Lesions retiniennes chez des patients VIH seropositifs 92
Markers of response to zidovudine monotherapy among treated HIV seroconverters 92
L’epatite post-trasfusionale non-A.non-B. Indagine sierologica in 85 soggetti con epatite acuta associata a trasfusione di sangue 92
Key questions in antiretroviral therapy: Italian Consensus Workshop (2005). 92
Sintesi intratecale di IgG in corso di infezioni da HIV 92
Prevalence of pol Gene Mutations in a Cohort of Antiretroviral-Naive Patients: Correlation with HIV RNA and CD4 Count at the Time of Genotypic Testing 92
Epatite non-A,non-B 92
Influence of gender, age, and transmission category on the progression from HIV seroconversion to AIDS 91
Pneumotorace in pazienti con sindrome da immunodeficienza acquisita 91
La diagnostica sierologica della epatite acuta da HAV 91
Mutations at Codons 10 and 36 of Protease Region in Absence of Primary Mutations May Correlate with Virological Outcome in Naive Patients Starting a PI-Containing HAART Regimen 91
Le infezioni da Herpes virus 91
Secondary mutations in the protease region of human immunodeficiency virus and virologic failure in drug-naive patients treated with protease inhibitor-based therapy 90
Diffuse necrotic hepatic lesions due to Visceral Leishmaniasis in AIDS 90
How many HIV-infected individuals may be defined as “long-term nonprogressors”? A report from the Italian seroconversion study 89
Persistence of e antigen as prognostic marker in acute hepatitis B 89
Premature vascular lesions in HIV-positive patients: a clockwork bomb that will explode? 89
Seconda infezione varicellosa in adulto affetto da AIDS 89
Giardiasis in HIV: a possible role in patients with severe immune deficiency 88
Randomized trial of trimethoprim-sulfamethoxazole versus pyrimethamine-sulfadiazine for therapy of toxoplasmic encephalitis in patients with AIDS. Italian Collaborative Study Group 88
Disease progression and early predictors of AIDS in HIV-seroconverted injecting drug users 88
Totale 10.350
Categoria #
all - tutte 68.798
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.798


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022550 0 4 2 6 63 21 25 70 85 59 51 164
2022/20233.153 222 19 101 263 255 380 2 184 1.556 24 67 80
2023/2024344 98 22 17 8 27 40 5 38 8 0 6 75
2024/20251.737 69 19 24 82 42 279 189 141 505 85 121 181
2025/20262.889 158 152 360 325 146 185 620 283 299 273 44 44
2026/202735 35 0 0 0 0 0 0 0 0 0 0 0
Totale 14.080